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Inflammation is a hallmark of brucellosis. Although Brucella abortus, one of the disease’s etiologic agents, possesses cytokine-stimulatory
properties, the mechanism by which this bacterium triggers a proinflammatory response is not known. We examined the mechanism
whereby heat-killed B. abortus (HKBA), as well as its LPS, induces production of inflammatory cytokines in monocytes/macrophages.
Polymyxin B, a specific inhibitor of LPS activity, did not inhibit the production of TNF-- and IL-6-induced HKBA in the human
monocytic cell line THP-1. HKBA induced the production of these cytokines in peritoneal macrophages of both C3H/HeJ and C3H/HeN
mice, whereas B. abortus LPS only stimulated cells from C3H/HeN mice. Anti-TLR2 Ab, but not anti-TLR4 Ab, blocked HKBA-
mediated TNF- and IL-6 production in THP-1 cells. Because bacterial lipoproteins, a TLR2 ligand, have potent inherent stimulatory
properties, we investigated the capacity of two B. abortus lipoproteins, outer membrane protein 19 (Omp19) and Omp16, to elicit a
proinflammatory response. Lipidated (L)-Omp16 and L-Omp19, but not their unlipidated forms, induced the secretion of TNF-, IL-6,
IL-10, and IL-12 in a time- and dose-dependent fashion. Preincubation of THP-1 cells with anti-TLR2 Ab blocked L-Omp19-mediated
TNF- and IL-6 production. Together, these results entail a mechanism whereby B. abortus can stimulate cells from the innate immune
system and induce cytokine-mediated inflammation in brucellosis. We submit that LPS is not the cause of inflammation in brucellosis;
rather, lipoproteins of this organism trigger the production of proinflammatory cytokines, and TLR2 is involved in this process. The
Journal of Immunology, 2004, 173: 4635–4642.
B acteria of the genus Brucella are Gram-negative, facul-tative intracellular organisms that cause severe disease inboth animals and humans. Brucellosis remains endemic
in many developing countries, where it undermines animal health
and productivity, causing important economic losses (1). It also
takes a toll in human health (2). Brucella organisms invade cells of
the reticuloendothelial system, and can be sequestered in macro-
phages at specific locations within the body, such as spleen, brain,
joints, heart, liver, and bone marrow (3). After infection, most
patients show an acute disease phase, which can progress either to
recovery or to chronicity. Inflammation is present both in the acute
and chronic phases of human brucellosis and in virtually all of the
organs affected by this disease. Clinical signs of such inflammation
are undulant fever, endocarditis, arthritis, osteomyelitis, meningi-
tis, pleocytosis, lymphocytic and monocytic infiltration of the
joints, orchitis, nephritis, hepatic granuloma, etc. (4).
With the growing realization that cytokines play a role in in-
flammation, research on cytokine-mediated inflammatory reac-
tions in brucellosis is receiving great attention. Studies conducted
to date have revealed that Brucella abortus can induce in a variety
of cell types the release of proinflammatory cytokines such as
IL-1 (5–7), IL-6 (6, 7), IL-12 (8–11), and TNF- (6, 7, 9–11).
These proinflammatory cytokines generally have potent effector
functions that overlap extensively with each other to bring about
the many components of inflammation, e.g., tissue necrosis (12),
chemotaxis of cellular infiltrates, induction of collagenase and PG
secretion by sinovial fibroblast and chondrocytes (13, 14), bone
resorption, and cartilage destruction (15), as well as a plethora of
microbicidal mechanisms (16). Thus, potent cytokine-stimulatory
properties possessed by B. abortus may explain the correlation
between tissue invasion and localized inflammation. B. abortus
also has been shown to induce the production of IL-10 (9, 17), a
cytokine that may eventually down-modulate the proinflammatory
response elicited by the bacterium (9).
The mechanism by which these bacteria trigger a proinflamma-
tory response is not known. Most features related to pathogenicity
seem to be concentrated or to act at the Brucella surface (18).
Among the factors possibly implicated, the unusual LPS molecule
located in the outer membrane of Brucella species has received
considerable attention (19). It has been demonstrated that most of
the biological activities induced by Brucella LPS are quantitatively
and qualitatively different from the classical enterobacterial LPS
(20, 21). Unlike many endotoxins, Brucella LPS is nonpyrogenic,
it does not induce a localized Shwartzman reaction, it fails to
increase the host’s susceptibility to histamine or to activate com-
plement, and is a very weak mitogen for murine B cells. At least
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100 times more Brucella LPS than enterobacterial LPS is required
to kill a host. As for induction of proinflammatory mediators, it has
been demonstrated that the biological activity of Brucella LPS is at
least 3 orders of magnitude lower than enterobacterial LPS (8, 9,
22). The weak biological activities induced by Brucella LPS seem
to be related to the unique structure of its lipid A (21, 23).
Alternatively, B. abortus could use its DNA to elicit a proin-
flammatory response. Bacterial DNA is enriched in unmethylated
CpG motifs that have been shown to activate the innate immune
system (24). However, it has been demonstrated that DNA from B.
abortus is relatively inefficient in eliciting cytokine production (9).
Recently, it has been shown that heat-killed B. abortus
(HKBA)3 induces the production of TNF- through a TLR2-de-
pendent pathway, independently of TLR4 and TLR9 (10). As LPS
and bacterial DNA use, respectively, TLR4 and TLR9 to stimulate
cytokine production, this finding supports the notion that B. abor-
tus LPS and DNA are not involved in eliciting proinflammatory
responses in brucellosis.
Studies conducted in our laboratory, as well as research done by
others, have demonstrated that bacterial lipoproteins, a TLR2 li-
gand (25), are able to stimulate cellular proliferation as well as
inflammatory cytokine production in normal cells. This phenom-
enon is caused by the lipid moiety of the protein (26–28). In ad-
dition, we have demonstrated that bacterial lipoproteins also can
elicit the production of IL-10, an anti-inflammatory cytokine, in
both human and monkey monocytes (29). Both autocrine and exo-
crine inhibition of IL-10 production resulted in an increase in the
production of the proinflammatory cytokines IL-6 and IL-12 (30).
The findings that lipoproteins can elicit not only inflammatory, but
also anti-inflammatory mediators, e.g., IL-10 from monocytes,
have added support to the contention that lipoproteins are crucial
factors in the pathogenesis of bacterial infections.
It has been demonstrated by molecular cloning and sequencing
that three genes encoding the outer membrane proteins (Omp) of
B. abortus, Omp10, Omp16, and Omp19, exhibit structural
features of bacterial lipoprotein precursors, namely, an amino-
terminal signal peptide ending with a tetrapeptide sequence that
conforms to the consensus sequence required for lipoprotein mod-
ification and processing (31, 32). The apparently correct process-
ing of Omp10, Omp16, and Omp19 in Escherichia coli suggests
that the pathway for lipoprotein maturation is functionally shared
between Brucella spp. and E. coli (32). Physicochemical and
functional analyses have recently confirmed that Omp10, Omp16,
and Omp19 are lipoproteins and that they are surface exposed (33).
It has also been demonstrated that these lipoproteins are present in
several Brucella strains. These strains represent all six Brucella
species and all their biovars.
As B. abortus LPS and DNA seem not to be involved in eliciting
an inflammatory response, it is conceivable that Brucella lipopro-
teins might be the molecules that stimulate the cells from the in-
nate immune system and induce cytokine-mediated inflammation
in brucellosis. To test this hypothesis, we cloned, expressed in E.
coli, and purified recombinant lipidated Omp16 (L-Omp16) and
Omp19 (L-Omp19) and used them as model stimulants. The use of
these (or any other) lipoproteins as a model is justified in so far as
their immunological effects are elicited by the lipid, not the protein
moiety. The lipid moiety is likely shared by all bacterial lipopro-
teins. As the model target cell we used the THP-1 human mono-
cytic cell line. These cells were used to ensure consistent results
(26, 30). We also stimulated the THP-1 cells with HKBA. B. abor-
tis cells were used to allow for inferences on whether lipoproteins
or LPS were the principal stimulants of monocytes/macrophages in
this bacterium. We present the results of this study in this article.
Materials and Methods
Mice
Four- to 6-wk-old female C3H/HeJ mice (obtained from The Jackson Lab-
oratory, Bar Harbor, ME) and C3H/HeN (obtained from Charles River
Laboratories, Wilmington, MA) were acclimated and randomly distributed
into experimental groups. Mice were kept in conventional animal facilities
and received water and food ad libitum.
Bacterial strains
E. coli strain JM109 (Promega, Madison, WI) was used as host during the
cloning experiments and for propagation of plasmids. BL21 (DE3) (Strat-
agene, La Jolla, CA) was used for expression of the recombinant proteins.
Bacterial strains were routinely grown at 37°C in Luria-Bertani broth or
agar, supplemented when required with 100 g/ml ampicilin. B. abortus
S2308 was cultured in Argentina in tryptose-soy agar supplemented with
yeast extract (Merck, Buenos Aires, Argentina). Bacterial numbers on sta-
tionary phase cultures were determined by comparing the OD at 600 nm
with a standard curve. Brucella organisms were washed five times for 10
min each in sterile PBS, heat killed by boiling for 20 min, aliquoted, and
stored at 70°C until used. Total absence of B. abortus viability subse-
quent to heat killing was verified by the absence of bacterial growth in
tryptose-soy agar.
Cloning, expression, and purification of recombinant lipidated
and unlipidated Omp16 and Omp19 from B. abortus
The open reading frames of Omp16 and Omp19 were cloned in the pET
22b vector (Novagen, Madison, WI). Briefly, the sequence information
previously reported by Tibor et al. (31, 32) was used to design specific
primers for the entire sequence with NdeI and XhoI restriction sites at the
5 ends. The primers were as follows: lipidated B. abortus Omp16 (L-Omp16),
forward, p1–5-CTCTGGCATATGCGCCGTATC-3; L-Omp16, reverse,
p2–5-TTGCCGCTCGAGCCGTCCGGCCCC-3; L-Omp19, forward, p1–
5-CTGGCCCATATGCAGAGCTCCCG-3; and L-Omp19, reverse, p2–5-
AAACTCGAGGCGCGACAGCGTCAC-3.
The unlipidated version of the Omps devoid of the putative signal peptide
and the N-terminal cysteine was cloned using different forward primers: un-
lipidated B. abortus Omp16 (U-Omp16), forward, p3–5-CGTTGCCATAT
GTGCGTCAAAGAA-3; U-Omp19, forward, p3–5-CCTGGCCATATGC
CAGAGCTCCCG-3.
B. abortus 544 genomic DNA was used as template for PCR with PFU
DNA polymerase (Stratagene). The ligation mix was used to transform
JM109 competent cells. Miniprep plasmid DNA was purified from over-
night cultures of 10 colonies using the Wizard Miniprep kit (Promega). The
resulting plasmids (pET-L-Omp16, pET-U-Omp16, pET-L-Omp19, pET-
U-Omp19) contained the genes with a COOH-terminal 6 histidine tag.
Competent E. coli BL21(DE3) (Stratagene) were transformed with the cor-
responding constructs, and rOmps were successfully expressed after in-
duction with isopropyl -D-thiogalactoside (1 mM). Recombinant
L-Omp16 and L-Omp19 were isolated from bacterial membranes by son-
ication and selective extraction by phase partitioning with 2% Triton X-114
(34). This preparation was further purified by affinity chromatography with
a Ni-NTA resin (Qiagen, Dorking, U.K.). U-Omp16 and U-Omp19 were
isolated from bacterial cytoplasm by sonication and were further purified
by affinity chromatography with a Ni-NTA resin (Qiagen). To eliminate
LPS contamination, rOmps were adsorbed with Sepharose-polymyxin B.
They contained 0.25 endotoxin U/g protein, as assessed by Limulus
amebocyte assay (Associates of Cape Cod, Woods Hole, MA). Protein
concentration was determined by the bicinchoninic acid method (Pierce,
Rockford, IL) using BSA as standard. The purified proteins were aliquoted
and stored at 70°C until used. Expression and purification of the recom-
binant proteins were monitored by SDS-PAGE, followed by silver staining.
Identity of Omps was confirmed by Western blot developed with anti-
Omp16 or anti-Omp19 mAbs.
LPS and lipoproteins
B. abortus 2308 LPS and E. coli O111 K58H2 LPS were provided by I.
Moriyon (University of Navarra, Pamplona, Spain). The purity and the
characteristics of these preparations have been published elsewhere (35).
LPS was solubilized in water by sonication at the appropriate concentration
3 Abbreviations used in this paper: HKBA, heat-killed B. abortus; Omp, outer mem-
brane protein; L-Omp, lipidated B. abortus Omp; L-OspA, lipidated B. burgdorferi
outer surface protein A; PS, poststimulation; U-Omp, unlipidated B. abortus Omp;
U-OspA, unlipidated B. burgdorferi outer surface protein A.
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and autoclaved before use. Recombinant lipidated Borrelia burgdorferi
outer surface protein A (L-OspA) and unlipidated outer surface protein A
(U-OspA) were obtained from J. Dunn, Brookhaven National Laboratories
(Brookhaven, NY).
Cells
THP-1 cells were obtained from the American Type Culture Collection
(Manassas, VA) and cultured, as previously described (26, 30). To induce
CD14 expression, the cells were cultured in 0.05 M 1,25-dihydroxyvita-
min D3 (Calbiochem-Novabiochem International, La Jolla, CA) for 48–72
h. Thioglycolate-elicited peritoneal macrophages were isolated, as previ-
ously described (36), from C3H/HeJ and C3H/HeN mice.
Stimulation of cytokine production
Vitamin D3-treated THP-1 cells or thioglycolate-elicited peritoneal mac-
rophages (1  106/ml) were cultured in flat-bottom polypropylene 48-well
plates (Corning, Corning, NY) in RPMI 1640 supplemented with 25 mM
HEPES buffer, 2 mM L-glutamine, 10% heat-inactivated FBS (HyClone,
Logan, UT), 100 U/ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml
fungizone per ml (RPMI 1640). For dose-response studies, cells were stim-
ulated with HKBA, L-Omp16, U-Omp16, L-Omp19, U-Omp19, B. abortus
LPS, E. coli LPS, L-OspA, or U-OspA at the indicated concentration.
Cultures were incubated at 37°C in a humidified atmosphere (5% CO2 and
95% air) for 24 h, except where indicated in the text. Where indicated,
cultures also contained 10 g/ml polymyxin B sulfate (Sigma-Aldrich, St.
Louis, MO). At the end of the culture, cells were centrifuged at 400  g
at 4°C for 10 min, and the supernatants were aliquoted and stored at 70°C
until they were used.
Blocking of TLRs
THP-1 cells (1  106/ml) were incubated with 20 g/ml anti-human TLR2
(clone TL2.1; eBioscience, San Diego, CA), anti-human TLR4 (clone
HTA125; eBioscience), or IgG2a isotype control for 30 min at 37°C. This
preparation was subsequently incubated with E. coli LPS, B. abortus LPS,
L-OspA, HKBA, or L-Omp19 to reach a final concentration of 10 ng/ml E.
coli LPS, 1000 ng/ml B. abortus LPS, 250 ng/ml L-OspA, 1  108 bac-
teria/ml HKBA, or 500 ng/ml L-Omp19 in a final volume of 0.5 ml. Cul-
tures were incubated for 2 or 24 h, as in the above paragraph, and super-
natants were assayed for TNF- or IL-6, respectively.
Kinetics of cytokine production
For the study of kinetics of cytokine production, cell-free supernatants
were collected after THP-1 cells had been stimulated for 2, 4, 8, 12, 24, 48,
and 72 h. The concentrations of stimulants used were 500 ng/ml L-OspA,
U-OspA, L-Omp16, U-Omp16, L-Omp19, U-Omp19, or 100 ng/ml E.
coli LPS.
Measurement of cytokine concentrations
Human IL-6, IL-12 (p40), IL-10, and TNF-, and mouse IL-6 and TNF-
were measured in culture supernatants by sandwich ELISA using paired
cytokine-specific mAbs, according to the manufacturer’s instructions (BD
Pharmingen, San Diego, CA).
Statistical analysis
Comparisons of cytokine production were made by the nonparametric
Mann-Whitney U test with the InStat 2 Software (GraphPad, San
Diego, CA).
Results
B. abortus is a more potent inducer of pro- and anti-
inflammatory cytokines than its LPS
The ability of HKBA and B. abortus LPS to induce the secretion
of pro- and anti-inflammatory cytokines in THP-1 cells was de-
termined. Cells were incubated with HKBA, B. abortus LPS, or E.
coli LPS as a control, and, after 24 h of culture, the production of
IL-6, IL-10, IL-12, and TNF- was quantified in the culture su-
pernatants by ELISA. The production of all cytokines was mark-
edly enhanced in culture supernatants of THP-1 cells that were
stimulated with HKBA when compared with the unstimulated
cells. Cytokine production was a function of the amount of bacteria
present in the culture. A significant ( p  0.0001) IL up-regulation
was detected in cultures containing between 1  107 and 1  109
bacteria/ml. Cytokine production in cultures that contained 1 
106 bacteria/ml or less dropped dramatically to the levels of un-
stimulated cells (Fig. 1). Conversely, B. abortus LPS was a weak
inducer of cytokine production. At concentrations comparable to
the concentrations estimated to be present in 1  107 to 1  109
bacteria/ml, B. abortus LPS induced the secretion of marginal
FIGURE 1. HKBA is a more potent inducer of pro- and anti-
inflammatory cytokines than B. abortus LPS. THP-1 cells (1  106/ml)
were incubated with supplemented medium (RPMI 1640), various concen-
trations of HKBA (from left to right, 105 to 109 bacteria/ml, in multiples of
10), various concentrations of B. abortus LPS (BruLPS) (from left to right,
10, 100, 500, and 1000 ng/ml), or E. coli LPS (EcLPS) (1, 10, and 100
ng/ml). After 24 h, TNF-, IL-6, IL-10, and IL-12 in the cell supernatants
were quantified by Ab capture ELISA. Results are expressed as the mean
(pg/ml)  SD. These experiments were performed twice in duplicate.
FIGURE 2. B. abortus LPS is not involved in the production of cyto-
kines mediated by HKBA. THP-1 cells (1  106/ml) were incubated for
24 h with RPMI 1640, various concentrations of HKBA, B. abortus LPS
(BruLPS) (1000 ng/ml), or E. coli LPS (EcLPS) (100 ng/ml) in the pres-
ence (f) or absence () of polymyxin B (PB). TNF- and IL-6 in the cell
supernatants were quantified by Ab capture ELISA. Results are expressed
as the mean (pg/ml)  SD. These experiments were performed twice in
duplicate.
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amounts of IL-10 and failed to induce IL-12 production (107 B.
abortus 2308 cells contain an estimate amount of 10 ng of LPS;
similar amounts of LPS have been informed to be present in B.
abortus RB51 cells (37)). B. abortus LPS was only able to induce
IL-6 and TNF- secretion in THP-1 cells, although significant
( p  0.0001) cytokine production was achieved at concentrations
of 100 ng/ml or higher (Fig. 1). These results indicate that HKBA
is able to induce the production of pro- and anti-inflammatory
cytokines in THP-1. They also suggest that due to its low biolog-
ical activity, B. abortus LPS seems not to be involved in eliciting
such response.
B. abortus LPS is not involved in the production of cytokines
mediated by HKBA
Experiments were then conducted to evaluate the contribution of
B. abortus LPS to the production of cytokines elicited by HKBA.
For that purpose, THP-1 cells were incubated with HKBA, B.
abortus LPS, or E. coli LPS in the presence or absence of poly-
myxin B, a specific inhibitor of the activity of LPS (38), and, after
24 h of culture, the production of IL-6 and TNF- was evaluated
in the culture supernatants by ELISA. Again, HKBA induced sig-
nificant production ( p  0.0001) of IL-6 and TNF- in a dose-
response fashion. IL secretion was not due to B. abortus LPS, as
the addition of polymyxin B had no effect on HKBA-induced cy-
tokine production under conditions in which it completely blocked
cytokine production in response to 100 ng/ml E. coli LPS and 1000
ng/ml B. abortus LPS (Fig. 2).
To further determine the contribution of B. abortus LPS to the
production of cytokines elicited by B. abortus, the production of
TNF- induced by HKBA was evaluated in peritoneal macro-
phages from LPS-nonresponder (TLR4-mutant) C3H/HeJ mice
stimulated with HKBA, B. abortus LPS, or E. coli LPS, as com-
pared with wild-type C3H/HeN mice. C3H/HeN cells treated with
B. abortus LPS and E. coli LPS produced TNF- in a dose-de-
pendent fashion. Both LPS preparations failed to induce TNF- in
cells from C3H/HeJ mice (Fig. 3). In contrast, HKBA was able to
elicit the same amounts of TNF- ( p  0.05) from peritoneal
macrophages of either mouse strain, indicating that HKBA acti-
vation is LPS independent (Fig. 3). Similar results were obtained
when IL-6 production was evaluated (data not shown).
Taken together, our results indicate that B. abortus LPS does not
contribute to the production of cytokines induced by HKBA. The
results also indicate that B. abortus LPS, but not HKBA, activates
macrophages through TLR4.
The production of cytokines induced by HKBA is TLR2
dependent
To further examine the role of the TLR4 and TLR2 in the cytokine
production induced by HKBA in human monocytes, THP-1 cells
were preincubated with anti-TLR2, anti-TLR4, or their respective
isotype controls, and then cultured with HKBA or B. abortus LPS.
The production of TNF- and IL-6 was evaluated in culture su-
pernatants by ELISA after culture. E. coli LPS and L-OspA were
used as controls. As expected, preincubation of THP-1 cells with
anti-TLR4 significantly blocked ( p  0.01) the E. coli LPS- and B.
abortus LPS-mediated production of both TNF- and IL-6,
whereas anti-TLR2 inhibited significantly ( p  0.01) the cytokine
production induced by L-OspA (Fig. 4). Anti-TLR2 also blocked
significantly ( p  0.01) the HKBA-mediated production of TNF-
and IL-6. In contrast, anti-TLR4 had no effect on this response
FIGURE 3. HKBA induction of TNF- secretion in vitro is TLR4 in-
dependent. Peritoneal macrophages from C3H/HeN and C3H/HeJ mice
were cultured with various concentrations of E. coli LPS (EcLPS), B. abor-
tus LPS (BruLPS), or HKBA. After 24 h, TNF- in the cell supernatants
was quantified by Ab capture ELISA. Each bar represents the mean  SD
of duplicate cultures. Data are representative of two separate experiments.
FIGURE 4. The production of cytokines induced by HKBA is TLR2
dependent. THP-1 cells (1  106/ml) were left untreated (), preincubated
with anti-TLR4 (f), anti-TLR2 (z), or IgG2a isotype control (p) for 30
min before the addition of E. coli LPS (EcLPS) (10 ng/ml), B. abortus LPS
(BruLPS) (1000 ng/ml), L-OspA (250 ng/ml), or HKBA (108 bacteria/ml).
After 2 or 24 h, TNF- or IL-6 in the cell supernatants was quantified by
Ab capture ELISA. Results are expressed as the mean (pg/ml)  SD. These
experiments were performed twice in duplicate.
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(Fig. 4). Isotype control mAbs had no effect on any of the re-
sponses studied. These results indicate that activation of mono-
cytes and cytokine production induced by B. abortus depends
on TLR2.
Cloning, expression, and purification of B. abortus Omp16 and
Omp19 lipoproteins
As cytokine production induced by HKBA proceeds via TLR2 and
taking into account that bacterial lipoproteins are potent inducers
of cytokines in a variety of cells (26–28) through a TLR2-medi-
ated pathway (25), we hypothesized that Brucella lipoproteins
could be responsible for the cytokine stimulation seen in HKBA-
stimulated THP-1 cells. To test this hypothesis, B. abortus lipopro-
teins Omp16 and Omp19 were cloned, expressed in E. coli, and
purified to use them as model lipoprotein stimulants. Additionally,
to investigate whether the active moiety of Omp16 and Omp19
was the N terminus tripalmitoyl-Cys moiety, the unlipidated ver-
sion of the Omps devoid of the putative signal peptide and the
N-terminal cysteine were cloned and purified. The recombinant
lipoproteins were expressed in E. coli strain BL21(DE3). The ex-
pressed proteins were purified using nickel affinity chromatogra-
phy. Each resulting preparation was of 95% purity (Fig. 5A). The
identity of the Omp16 and Omp19 was assessed using specific
mAbs. L-Omp16 and L-Omp19 have a similar m.w. than that of
the native proteins (Fig. 5B). The mAb against Omp16 detected an
additional band of slightly higher molecular mass in the L-Omp16
preparation (Fig. 5B). As protein acylation is a posttranslational
modification, this band may correspond to a precursor form of
Omp16 (33).
B. abortus lipoproteins Omp16 and Omp19 induce the
production of pro- and anti-inflammatory cytokines in the THP-
1 cell line
The ability of Omp16 and Omp19 to induce the secretion of pro-
and anti-inflammatory cytokines in THP-1 cells was determined.
Cells were incubated with L-Omp16, U-Omp16, L-Omp19, or U-
Omp19, and, after 24 h of culture, the production of IL-6, IL-10,
IL-12, and TNF- was evaluated in the culture supernatants by
ELISA. L-OspA and E. coli LPS were used as control. L-Omp16
and L-Omp19 induced IL-6, IL-10, IL-12, and TNF- in a dose-
dependent fashion. Significant cytokine production ( p  0.001)
was seen with as little as 1 ng/ml L-Omp19, and maximum pro-
duction was achieved with 1000 ng/ml (Fig. 6). Both Omps were
similarly effective in the induction of TNF-. L-Omp16 induced
significant amounts ( p  0.001) of IL-6, IL-10, and IL-12 at 10–
100 ng/ml. Cytokine production by lipoprotein-stimulated THP-1
cells was dependent on the lipidation of the molecules, as
U-Omp16 and U-Omp19 failed to induce IL-6, IL-10, IL-12, and
TNF- at all the concentrations tested (Fig. 6). To ensure that the
cytokine production was not due to E. coli LPS that might have
been copurified with the rOmps, cultures were incubated with or
without polymyxin B. Cytokine secretion was not due to LPS con-
tamination, as the addition of polymyxin B had no effect on
L-Omp16- or L-Omp19-induced cytokine production under con-
ditions in which it completely blocked cytokine production in re-
sponse to 100 ng/ml E. coli LPS (Fig. 6). As expected, L-OspA
induced high levels of all cytokines tested, and these levels were
not affected by the addition of polymyxin B. These results dem-
onstrate that B. abortus lipoproteins induced pro- and anti-
FIGURE 5. Purification and identification of B. abortus Omp16 and
Omp19 lipoproteins. Recombinant U-Omp16, L-Omp16, U-Omp19, and
L-Omp19 were purified by affinity chromatography, run on a 12% SDS-
PAGE gel, and silver stained (A). L-Omp16, L-Omp19, and HKBA were
run on a 15% SDS-PAGE gel, transferred to a nitrocellulose membrane,
and revealed with anti-Omp16 or anti-Omp19 mAbs (B).
FIGURE 6. B. abortus lipoproteins induce pro-
and anti-inflammatory cytokines in THP-1 cells.
THP-1 cells (1  106/ml) were incubated for 24 h
with RPMI 1640, E. coli LPS (EcLPS) (100 ng/
ml), L-Ospa (500 ng/ml), U-OspA (500 ng/ml), or
various concentrations of L-Omp19, U-Omp19, L-
Omp16, and U-Omp16 (from left to right, 1, 10,
100, 500, and 1000 ng/ml) in the presence (f) or
absence () of polymyxin B (PB). TNF-, IL-6,
IL-10, and IL-12 in the cell supernatants were
quantified by Ab capture ELISA. Results are ex-
pressed as the mean (pg/ml)  SD. These experi-
ments were performed twice in duplicate.
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inflammatory cytokines in THP-1 cells. The results also indicate
that the lipid modification of Omp16 and Omp19 is essential for
the induction of cytokines in monocytes.
The kinetics of cytokine production by THP-1 cells also was
determined using L-Omp16, U-Omp16, L-Omp19, U-Omp19, L-
OspA, and E. coli LPS as stimulants. Cytokine concentrations
were determined at 2, 4, 8, 16, 24, 48, and 72 h after adding the
stimulants to the cultures. Neither U-Omp16 nor U-Omp19 alone
induced the production of any cytokine at any time (data not
shown). The concentrations of all of the cytokines studied in-
creased rapidly within the first 20 h of stimulation with L-Omp16,
L-Omp19, L-OspA, and E. coli LPS. After this time, cytokine
concentrations either continued to increase at a lesser rate (IL-6
and IL-12) or declined gradually (IL-10 and TNF-) (Fig. 7). The
concentration of TNF- reached its peak value at 2 h poststimu-
lation (PS), and declined sharply thereafter. The IL-10 concentra-
tion peaked between 8 and 16 h PS and declined thereafter. The
concentrations of both IL-6 and IL-12 increased more slowly than
those of the previous two cytokines and reached a plateau by
48 h PS.
TLR2 mediates the production of cytokines induced by B.
abortus lipoproteins
TLR2 has been shown previously to mediate responses to bacterial
lipoproteins in cells of the monocytic lineage (39). Consequently,
the role of TLR2 in mediating B. abortus lipoprotein-induced cy-
tokine production was tested. THP-1 cells were preincubated with
anti-TLR2 Ab, anti-TLR4 Ab, or their respective isotype controls,
and then cultured with HKBA or L-Omp19. The production of
TNF- and IL-6 was evaluated in culture supernatants by ELISA
after culture. Preincubation of THP-1 cells with anti-TLR2 signif-
icantly blocked ( p  0.01) L-Omp19-mediated production of both
TNF- and IL-6. Anti-TLR2 also inhibited significantly ( p 
0.01) the HKBA-mediated production of TNF- and IL-6 (Fig. 8).
Anti-TLR4 Ab or isotype control Ab had no effect on any of the
responses investigated. These results indicate that production of
cytokines induced by B. abortus lipoproteins is TLR2 dependent.
Discussion
The clinical manifestations of human brucellosis are protean. Yet,
despite the diversity of clinical signs and symptoms, inflammation
is a hallmark of this disease. Intermittent inflammatory arthritis is
present in the early phases of brucellosis in humans, and some
patients may go on to develop chronic inflammatory arthritis that
resembles other forms of human inflammatory arthritis (4). Syno-
vial tissue characteristically reveals a lymphocytic infiltrate and
hyperplasia of synovial lining cells (40). Joint damage is often
associated with presence of Brucella organisms in these joints, as
was shown by in vitro culture of synovial tissue and fluid (41). In
the liver, Brucella infections induce hepatic lesions that can be
both granulomatous and nongranulomatous (42, 43). Histologi-
cally, granulomas show central necrosis, a polymorphic cellular
infiltrate, few giant cells, and peripheral fibrosis (44). The most
characteristic sign of inflammation in neurobrucellosis is menin-
gitis, which is caused by invasion of the CNS by Brucella (45).
Examination of the cerebrospinal fluid in Brucella meningitis gen-
erally reveals an elevated protein content and lymphocytic pleo-
cytosis (45). Surgical biopsies of brain or meninges and postmor-
tem examinations of nerve tissue yield evidence of perivascular
lymphocytic infiltrates and of granuloma formation (45).
In domestic ruminants, the signs of inflammation are orchitis in
males and placentitis in females (46). Brucella organisms can in-
fect the bovine placenta and induce abortion. Macrophages, im-
munoreactive for Brucella Ags, neutrophils, and lymphocytic
cells, can be present in the placental cellular infiltrates (47).
Although enterobacterial LPS has been clearly documented to
play a central role in the pathogenesis of Gram-negative bacterial
infections (48), the capacity of Brucella LPS to elicit an inflam-
matory response has been questioned (9, 10, 22). In this study, we
present evidence indicating that the production of inflammatory
FIGURE 7. Kinetics of cytokine production by THP-1 cells in response
to B. abortus lipoproteins. THP-1 cells (1  106/ml) were incubated with
E. coli LPS (EcLPS) (100 ng/ml), L-OspA (500 ng/ml), L-Omp19 (500
ng/ml), or L-Omp16 (500 ng/ml), and cell-free supernatants were collected
at 2, 4, 8, 12, 24, 48, and 72 h after addition of stimulants. TNF-, IL-6,
IL-10, and IL-12 in the cell supernatants were quantified by Ab capture
ELISA. Results are expressed as the mean (pg/ml)  SD. These experi-
ments were performed twice in duplicate.
FIGURE 8. The production of cytokines induced by B. abortus lipopro-
teins is TLR2 dependent. THP-1 cells (1  106/ml) were left untreated (),
preincubated with anti-TLR4 (f), anti-TLR2 (z), or IgG2a isotype control
(p) for 30 min before the addition of L-Omp19 (500 ng/ml) or HKBA (108
bacteria/ml). After 2 or 24 h, TNF- or IL-6 in the cell supernatants was
quantified by Ab capture ELISA. Results are expressed as the mean (pg/
ml)  SD. These experiments were performed twice in duplicate.
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cytokines induced by B. abortus is independent of its LPS. HKBA
induced the production of TNF- and IL-6 in peritoneal macro-
phages of both C3H/HeJ and C3H/HeN mice, whereas B. abortus
LPS only stimulated cells from C3H/HeN mice. Moreover, poly-
myxin B, a specific inhibitor of the activity of LPS (38), was un-
able to inhibit the production of TNF- and IL-6 induced by
HKBA in THP-1 cells.
Because bacterial lipoproteins have potent inherent stimulatory
properties (26–28), we hypothesized that B. abortus lipoproteins
were responsible for the inflammation associated with infection (4,
45). L-Omp16 and L-Omp19 induced the secretion of TNF-,
IL-6, IL-10, and IL-12 in a time- and dose-dependent fashion.
Neither U-Omp16 nor U-Omp19 induced cytokine secretion in
THP-1 cells, demonstrating that acylation of the lipoprotein mol-
ecule is required for the production of cytokines in cells of the
monocyte/macrophage lineage. L-Omp16 and L-Omp19 were
equally potent in inducing TNF- production. L-Omp16 was less
efficient in inducing IL-6, IL-10, and IL-12. The reasons for this
difference are unknown, but may relate to heterogeneity in the
lipidation of the Omp16 preparation (see Fig. 5B). As different
TLR are involved in the signaling of fully and partially acylated
lipoproteins (49, 50), it is possible that the array of TLRs (and
other) receptors involved in transducing the Omp16 signal toward
production of IL-6, IL-10, and IL-12 is less efficient with partly
acylated Omp16 than with Omp19, which is uniformly acylated. In
that respect, experiments conducted with TLR knockout mice in-
dicated that different TLR-mediated signaling pathways may result
in the selective induction of anti-inflammatory or proinflammatory
cytokines (49).
The lipid modification of B. abortus lipoproteins is likely to be
identical in all of the lipoprotein molecules of this organism. This
entails that other lipoproteins also would have the ability to induce
cytokine production. Because the B. abortus genome contains no
less than 80 genes encoding putative lipoproteins (D. Comerci,
unpublished observations), it follows that lipoprotein-induced pro-
duction of proinflammatory mediators could be potent enough to
explain why it is that inflammation in brucellosis is manifestly
overt even when the bacteria are hard to find in lesions or bodily
fluids. These results also indicate that innate immune responses,
together with bacterial persistence in the tissues, might lead to the
inflammatory pathology of brucellosis. Indeed, splenocytes from
mice with the scid mutation (scid mice), which are devoid of T and
B cells, but have monocytes, produced similar levels of IL-6 than
did splenocytes from immunocompetent mice when stimulated
with HKBA in vitro (51).
Purified B. abortus LPS dispensed at high concentrations (1 g/
ml) was able to induce the production of TNF- and IL-6 in mono-
cytes. This result, obtained in vitro, is probably not relevant phys-
iologically. As many as 108 Brucella cells/ml, a bacillary
concentration not likely to occur in vivo, elicited comparable cy-
tokine levels, but by a pathway that could not be inhibited with
polymyxin B. Hence, not even this high bacterial concentration has
enough available LPS for the latter to be functionally detectable.
Our findings demonstrate that Brucella lipoproteins can induce
not only inflammatory cytokines, but also IL-10, a potent anti-
inflammatory cytokine, in the same cell type, the monocyte. That
these cytokines could thus act in concert within the same micro-
environment of B. abortus-infected tissues underscores the con-
tention that IL-10 may play a role in the control of inflammation in
brucellosis (9). Moreover, the ability of B. abortus lipoproteins to
induce anti-inflammatory cytokines such as IL-10 might explain
the focal and transient nature of inflammatory episodes during
Brucella infections (4).
The relative involvement of TLR2 and TLR4 in mediating B.
abortus-induced cytokine production merits discussion. Our re-
sults indicate that HKBA induces production of TNF- and IL-6
via TLR2, and agree in this regard with the results obtained by
Huang et al. (10). In these investigators’ hands, HKBA also in-
duced TNF- production in mouse cells via TLR2. In contrast,
Campos et al. (11) obtained evidence to suggest that production of
TNF-, as induced by HKBA, was TLR4 dependent. Both inves-
tigations demonstrated, as ours did too, that B. abortus LPS uses
TLR4. We showed, moreover, in agreement with the results of
Huang et al., that LPS is not a mediator of the proinflammatory
activity of HKBA, and provided, in addition, proof of concept that
B. abortus lipoproteins would be the TLR2 ligands used by the
bacterium to trigger the release of pro- and anti-inflammatory
mediators.
HKBA has been proposed as a powerful adjuvant and vaccine
carrier, due to its ability to induce a vigorous Th1 response, by
promoting IL-12 production in cells of the innate immune system
(8, 10). Our results indicate that this IL-12-mediated Th1-promot-
ing activity may be due to a single type of molecule: Brucella
lipoproteins. If the nature of the adjuvant activity of B. abortus
lipoproteins is the same as that of the whole bacterium, the devel-
opment of more effective Th1-inducing adjuvants based on B.
abortus-derived components should be greatly simplified.
Finally, the finding that purified L-Omp16 and L-Omp19 stim-
ulate cytokine production by cells from the innate immunity may
be important in disease pathogenesis. The invasion of spleen,
brain, joints, heart, liver, and bone marrow by Brucella organisms
would allow the introduction of these potent molecules into the
tissues. The interaction of Omp16 and Omp19, or other B. abortus
lipoproteins, with resident cells such as macrophages could cause
cytokine production, proliferation, and recruitment of inflamma-
tory cells, leading to tissue inflammation. This supports a model in
which at least three factors contribute to the development of cy-
tokine-mediated inflammation in brucellosis. These factors are
bacterial tissue invasion and persistence, interaction of lipoproteins
with effector cells, and regulation of this effect by modulatory cy-
tokines produced in the microenvironment of the invaded tissues.
In view of our results, it may be that the pathologic fate of bru-
cellosis, in particular the transient and recurrent nature of the dis-
ease’s inflammatory episodes, depends on a delicate balance be-
tween pro- and anti-inflammatory responses that are elicited by
brucellar lipoproteins.
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lez, U. Zähringer, E. Moreno, and I. Moriyón. 2000. Brucella abortus and its
closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane per-
meability and cationic peptide resistance. Infect. Immun. 68: 3210.
36. Munford, R. S., and C. L. Hall. 1985. Uptake and deacylation of bacterial lipo-
polysaccharides by macrophages from normal and endotoxin-hyporesponsive
mice. Infect. Immun. 48:464.
37. Neidhardt, F. C., J. L. Ingraham, and M. Schaechter. 1990. Physiology of the
Bacterial Cell. Sinauer Associates, Sunderland, p. 4.
38. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A
portion of bacterial lipopolysaccharides. Immunochemistry 13:813.
39. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis,
R. M. Wooten, and J. J. Weis. 1999. Cutting edge: inflammatory signaling by
Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol.
163:2382.
40. Gotuzzo, E., G. S. Alarcon, T. S. Bocanegra, C. Carrillo, J. C. Guerra, I. Rolando,
and L. R. Espinoza. 1982. Articular involvement in human brucellosis: a retro-
spective analysis of 304 cases. Semin. Arthritis Rheum. 12:245.
41. Kelly, P. J., W. J. Martin, A. Schirger, and L. A. Weed. 1960. Brucellosis of the
bones and joints: experience with sixty-six patients. J. Am. Med. Assoc. 174:347.
42. Young, E. J. 1979. Brucella melitensis hepatitis: the absence of granulomas. Ann.
Intern. Med. 91:414.
43. Jordans, H. G., and K. D. DeBruin. 1980. Granulomas in Brucella melitensis
infection. Ann. Intern. Med. 92:264.
44. Colmenero, J. D., M. I. Queipo-Ortuno, M. J. Reguera, A. M. Suarez-Munoz,
S. Martin-Carballino, and P. Morata. 2002. Chronic hepatosplenic abscesses in
brucellosis: clinico-therapeutic features and molecular diagnostic approach. Di-
agn. Microbiol. Infect. Dis. 42:159.
45. Bouza, E., M. Garcia de la Torre, F. Parras, A. Guerrero, M. Rodriguez-Creixems,
and J. Gobernado. 1987. Brucellar meningitis. Rev. Infect. Dis. 9:810.
46. Enright, F. M. 1990. The pathogenesis and pathobiology of Brucella infection in
domestic animals. In Animal Brucellosis. K. Nielsen and J. R. Duncan, eds. CRC
Press, Boca Raton, p. 301.
47. Palmer, M. V., N. F. Cheville, and A. E. Jensen. 1996. Experimental infection of
pregnant cattle with the vaccine candidate Brucella abortus strain RB51: patho-
logic, bacteriologic, and serologic findings. Vet. Pathol. 33:682.
48. Beutler, B. 2002. LPS in microbial pathogenesis: promise and fulfillment.
J. Endotoxin Res. 8:329.
49. Alexopoulou, L., V. Thomas, M. Schnare, Y. Lobet, J. Anguita, R. T. Schoen,
R. Medzhitov, E. Fikrig, and R. A. Flavell. 2002. Hyporesponsiveness to vacci-
nation with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-
deficient mice. Nat. Med. 8:878.
50. Takeuchi, O., T. Kawai, P. F. Muhlradt, M. Morr, J. D. Radolf, A. Zychlinsky,
K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-
like receptor 6. Int. Immunol. 13:933.
51. Liu, Z., and C. Cheers. 1993. The cellular source of interleukin-6 during Listeria
infection. Infect. Immun. 61:2626.
4642 Brucella LIPOPROTEINS INDUCE INFLAMMATION IN BRUCELLOSIS
